Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases.
Ontology highlight
ABSTRACT: Clinical decision-making for patients with breast cancer (BC) is still primarily based on biomarker characteristics of the primary tumor, together with the evaluation of synchronous axillary lymph node metastasis (LNM). In this study, we investigated the prevalence of discordance in the biomarkers and surrogate subtyping between the primary BC and the LNM, and whether subsequent changes would have altered clinical treatment recommendations. In this retrospective study, 94 patients treated for unifocal primary BC and synchronous LNM at Sahlgrenska UniversityHospital during 2018 were included. Estrogen (ER) and progesterone (PR) receptor, Ki67, and HER2 status were assessed in the primary tumor and LNM using immunohistochemistry. Discordances between the primary tumor and the LNM were analyz
SUBMITTER: Janeva S
PROVIDER: S-EPMC10338601 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA